Yonhap Infomax NewsJan 18
Samsung Biologics announced plans to enhance its CDO and CRO capabilities, leveraging its CMO expertise, with new service launches and a focus on data-driven, multi-modality solutions.
#YonhapInfomax #SamsungBiologics #CDO #CRO #CMO #ContractDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100390
Samsung Biologics to Strengthen CDO and CRO Capabilities Leveraging CMO Competitiveness

Samsung Biologics announced plans to enhance its CDO and CRO capabilities, leveraging its CMO expertise, with new service launches and a focus on data-driven, multi-modality solutions.

Yonhap Infomax